Seasonal variation in Ménière disease: a systematic review and meta-analysis
Abstract
Background: The relationship between seasonal variation and Ménière disease (MD) has not been fully elucidated. This meta-analysis aimed to investigate the association between seasonal patterns and the occurrence of MD.
Methods: We systematically searched relevant observational studies in PubMed, Embase, Web of Science, the Cochrane Library, and major Chinese databases from inception to July 2025. The subjects included in the study were patients with MD. Seasonal occurrence of MD was the primary outcome. Study quality was assessed using the Newcastle-Ottawa Scale (NOS) and the Joanna Briggs Institute (JBI) critical appraisal scale. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using Stata 18.0, and heterogeneity was assessed using the I 2 statistic.
Results: A total of five observational studies involving 1,001,636 participants were included in the meta-analysis. With summer as the reference, ORs for spring, winter and autumn were 1.03 (95% CI 1.02-1.04), 0.92 (95% CI 0.91-0.93) and 1.04 (95% CI 0.85-1.26), respectively. Subgroup and sensitivity analysis confirmed the robustness of the findings, showing that the overall estimate was not fully driven by one single study.
Conclusion: Our meta-analysis suggests that the occurrence of MD may exhibit seasonal variation across published studies, with seasonal fluctuations characterized by slightly higher occurrence in spring and declining occurrence in winter. The finding may inform patient education…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,001,636 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.